MRK  Merck & Company Inc.




Consumer Durables


Major Pharmaceuticals

Market Cap.


Vuru Grade


Current Price

+0.80 (+1.28%)

Growth Price

Overvalued by 14.05%

Stability Price

Overvalued by 67.60%

Company Metrics

  • P/E 34.76
  • P/S 4.39
  • P/B 3.99
  • EPS 1.82
  • Cash ROIC 12.97%
  • Cash Ratio 0.70
  • Dividend 1.84 / 2.92%
  • Avg. Vol. 9.62M
  • Shares 2.77B
  • Market Cap. 175.23B

Company Description

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company's Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, ... more

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


Better Buy: Merck & Co., Inc. vs. Pfizer
Motley Fool - Sep 12, 2016
For pharma giants Merck (NYSE:MRK) and Pfizer (NYSE:PFE), however, the fear of potential new regulation hasn't led to a big decline in their share prices over time, and the growth trends toward greater use of pharmaceuticals both in the U.S. and around ...
The Key Numbers To Watch From Merck & Co., Inc. (NYSE:MRK)'s Earnings
The Voice Registrar - Sep 27, 2016
Merck & Co., Inc. (NYSE:MRK) plunged -1.29 per cent to reach at the trading price of $62.15 as it is set to release its next quarterly earnings report on October 25, 2016.
Current Merck & Co., Incorporated (NYSE:MRK) PT Means Stock Is Worth Almost $82 - Review Fortune
A look at a High Market Cap Stock: Merck & Co., Inc., MRK - The Daily Leicester
Analyst Views To Note Merck & Co., Inc. (MRK), American Express Company (AXP)
Review Fortune - Sep 27, 2016
Merck & Co., Inc. (NYSE:MRK) remained bearish with a decrease -1.29% putting the price on the $62.15 per share in last trading session ended on 9/26/2016.
Analysts' Recommendations Stocks in Focus: Merck & Co., Inc. (NYSE:MRK ... - Money News
Stocks Trending Alert: VEREIT (VER), Merck (MRK), American Express (AXP) - iStreetWire
Merck to Hold Third-Quarter 2016 Sales and Earnings Conference Call on October 25
Business Wire (press release) - Sep 23, 2016
This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S.
Influential Analyst Rating Changes: Merck & Co., Inc. (NYSE:MRK), Macy's, Inc ... - TWN
Merck & Co., Inc. (NYSE:MRK) Analyst Research Summary - The Independent Republic
Merck & Co., Inc. (NYSE:MRK) Fundamental Star Rating Report
CML News - 16 hours ago
This is a fundamental star rating report for Merck & Co., Inc. (NYSE:MRK) . The Capital Market Laboratories Star Rating is an objective, quantifiable measure of a company's operating and financial condition.
Analysts' Recommendations Stocks in Focus: Merck & Co., Inc. (NYSE:MRK ...
Money News - 19 hours ago
On Tuesday, Shares of Merck & Co., Inc. (NYSE:MRK) gained 0.68% to $62.57. The share price is trading in a range of $61.83 - 62.70.
The Insider Activity Don't Lie: Merck & Co., Inc. (NYSE:MRK)
Review Fortune - Sep 20, 2016
Merck & Co., Inc. (NYSE:MRK) down -2.23% for the past 5 days, is under coverage of 0 analysts who collectively assign a hold rating on stock.
Merck & Co., Inc. (NYSE:MRK) Near to Lift Curtain on September 2016 Earnings - The Voice Registrar
Considerable Analyst Ratings: Merck & Company, Inc. (NYSE:MRK) , Ionis ... - Is stories
Sanofi SA (ADR) (SNY) Sues Merck & Co., Inc. (MRK) Over Multiple Patent ... - Sep 19, 2016
Sanofi SA (ADR) (NYSE:SNY) is suing Merck & Co., Inc. (NYSE:MRK) for what it claims are several instances of patent infringement.
Sanofi Files Suit Against Merck, Claiming Patent Infringements - Wall Street Journal
Sanofi Files U.S. Suit Against Merck on Patent Infringements - Nasdaq
One Put, One Call Option To Know About for Merck & Co.
Nasdaq - Sep 26, 2016
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co., Inc (Symbol: MRK). So this week we highlight one interesting put contract, and one interesting call contract, from the ...
Merck & Co., Inc. (NYSE:MRK): Updated Analyst Ratings
Review Fortune - Sep 15, 2016
Merck & Co., Inc. (NYSE:MRK) down -1.7% for the past 5 days, is under coverage of 22 analysts who collectively assign a hold rating on stock.